Results 1 to 10 of about 126,067 (267)
Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma [PDF]
Frontiers in Pediatrics, 2022 Tiotropium bromide is the only long-acting muscarinic antagonist (LAMA) approved for treatment of patients aged ≥6 years old who have symptoms of uncontrolled asthma.
Francesca Santamaria +4 more
doaj +10 more sources
Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD [PDF]
International Journal of COPD, 2016 José Luis Izquierdo,1 José Manuel Paredero,2 Raul Piedra3 1Department of Pneumology, Hospital Universitario de Guadalajara, 2Department of Pharmacy, 3Department of Primary Care, Guadalajara Integrated Care Management, Guadalajara, Spain ...
Izquierdo JL, Paredero JM, Piedra R
doaj +10 more sources
Bronchodilator treatment of stable COPD: long-acting anticholinergics [PDF]
European Respiratory Review, 2005 Since airflow obstruction in chronic obstructive pulmonary disease (COPD) is to some extent reversible, bronchodilators play an important role in the maintenance treatment of COPD the more they reduce hyperinflation and, as a result, improve dyspnoea and
W. Vincken
doaj +6 more sources
Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2017 Inhaled, long-acting anticholinergic medication (LAA), commonly used for moderate-to-severe chronic obstructive pulmonary disease (COPD), has been shown to decrease COPD hospitalizations, emergency department visits, and acute exacerbations but has also ...
Andrea S Gershon +2 more
exaly +5 more sources
Annals of Pharmacotherapy, 2017 Background:No studies have examined adherence or persistence to long-acting anticholinergics (LAAC) treatment episodes in patients with chronic obstructive pulmonary disease (COPD).
Marie-France Beauchesne +2 more
exaly +5 more sources
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma? [PDF]
European Respiratory Review, 2016 Asthma is a chronic inflammatory disorder of the airways that is a major global burden on both individuals and healthcare systems. Despite guideline-directed treatment, a significant proportion of patients with asthma do not achieve control.
William W. Busse +3 more
doaj +3 more sources
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]
Cochrane Database of Systematic Reviews, 2014 BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...
Christopher J Cates +8 more
core +6 more sources
The mode of action of anticholinergics in asthma [PDF]
European Respiratory Journal, 2018 Acetylcholine binds to muscarinic receptors to play a key role in the pathophysiology of asthma, leading to bronchoconstriction, increased mucus secretion, inflammation and airway remodelling. Anticholinergics are muscarinic receptor antagonists that are
Reinoud Gosens, Nicholas Gross
exaly +3 more sources
Медицинский совет, 2021 Inhaled short-acting bronchodilators (beta-agonists and M-anticholinergics) have been used for a long time in patients with bronchoobstructive diseases, the main representatives of which are chronic obstructive pulmonary disease (COPD) and bronchial ...
K. A. Zykov +6 more
doaj +3 more sources